Several Indian news outlets report that an American woman has shared an online claim comparing medication prices between the United States and India. The woman reportedly says a medicine that costs about $1,000 in the U.S. was available to her for around $25 when purchased through an Indian manufacturer. NDTV and Mint frame her comments as criticism of the U.S. healthcare system, describing her assertion that it is a “scam.” Times of India similarly reports that she criticizes the U.S. system, while noting the broader price comparison using Indian rupee figures—Rs 95,000 versus Rs 800. Across the reports, the central issue is the large price gap she cites for the same medication when obtained in India compared with the price she associates with the U.S. healthcare market. The articles do not provide additional clinical details about the medication, verification of pricing, or independent confirmation of the comparison, but they consistently describe the allegation and the public discussion it sparks online.